ADVFN US – Market Content Editor
-
Wolfspeed Shares Jump After Securing $698.6 Million IRS Refund
Wolfspeed Inc. (NYSE:WOLF) saw its stock climb 10.4% in premarket trading on Monday after announcing it has received $698.6 million in cash tax refunds from the Internal Revenue Service. The refund was issued under the Advanced Manufacturing Investment Credit in Section 48D of the U.S. tax code and accounts for a sizable portion of the…
-
Intercont (Cayman) Shares Skyrocket After Announcing Major Low-Carbon Shipping Partnership
Intercont (Cayman) Limited (NASDAQ:NCT) surged 47% in premarket trading on Monday after the company unveiled a new strategic partnership between its Singapore subsidiary, Openwindow, and CINCO INTERNATIONAL HONGKONG LIMITED. The collaboration is expected to deliver roughly $118.25 million in cumulative contract revenue and an estimated $88.96 million in cumulative net profit. The agreement focuses on…
-
ProMIS Neurosciences Shares Advance After New Data Supports Alzheimer’s Trial Strategy
ProMIS Neurosciences Inc. (NASDAQ:PMN) rose 6% on Monday after new research findings bolstered confidence in the company’s biomarker-focused approach to Alzheimer’s disease drug development. The company said a peer-reviewed paper published in Alzheimer’s & Dementia: Translational Research & Clinical Interventions found that plasma phosphorylated tau (pTau) biomarkers may serve as reliable early indicators of clinical…
-
FuelCell Energy Shares Decline After Company Secures $25 Million in EXIM Financing
FuelCell Energy Inc. (NASDAQ:FCEL) slid 4.3% on Monday following news that the company has finalized a new debt financing agreement with the Export-Import Bank of the United States (EXIM). The deal will provide roughly $25 million in gross proceeds before fees and reserves, giving the company additional capital to support its international growth plans, particularly…
-
IDEAYA Biosciences Shares Climb After FDA Clears Bispecific ADC Candidate
IDEAYA Biosciences Inc. (NASDAQ:IDYA) advanced 5.1% in premarket trading on Monday after revealing that the FDA has cleared its investigational new drug (IND) application for IDE034, a potential first-in-class bispecific B7H3/PTK7 TOP1 antibody-drug conjugate. The oncology-focused precision medicine company expects to launch a Phase 1 clinical trial in the first quarter of 2026. The initial…
-
Five Market Themes to Watch in the Week Ahead
A heavy slate of U.S. economic data will dominate attention this week as investors look to assess the health of the American economy before the Federal Reserve’s next rate decision. Expectations for a rate cut at next week’s meeting have been rising, but the upcoming indicators could offer a new—though delayed—window into inflation trends and…
-
Crypto-Linked Stocks Sink as Fresh Bitcoin Selloff Hammers the Sector
Companies tied to the cryptocurrency market slumped on Monday as another wave of Bitcoin (COIN:BTCUSD) selling pressured exchanges, miners, and firms with exposure to digital assets. Bitcoin dropped about 4.4% to $86,429, deepening a retreat that followed its worst monthly performance since the 2021 crypto crash. The decline coincides with a broader risk-off shift at…
-
Canadian Solar Shares Jump 12% After Company Reclaims Direct Control of U.S. Operations
Canadian Solar Inc. (NASDAQ:CSIQ) rallied 12% on Monday after announcing that it will resume direct management of its U.S. business activities while continuing to shift more of its manufacturing footprint back to North America. The company plans to establish new joint ventures with U.S. investors and its majority-owned unit, CSI Solar Co., Ltd. As part…
-
Barrick Shares Gain as Miner Considers IPO for North American Gold Portfolio
Barrick Mining Corporation (NYSE:B) (TSX:ABX) climbed 4.6% on Monday after revealing that it is evaluating a potential initial public offering for a newly created entity housing its top North American gold assets. The company said its Board of Directors has unanimously authorized management to assess the possibility of forming a subsidiary that would include Barrick’s…
-
Hafnia Shares Slip 2% Even as Q3 Results Top Expectations
Hafnia Limited (NYSE:HAFN) posted better-than-expected third quarter results on Monday, reporting earnings per share of $0.18, ahead of the $0.16 analysts had forecast. Revenue also came in far stronger than anticipated at $366.5 million, beating the consensus projection of $253.52 million. Despite the impressive beat on both the top and bottom lines, the stock fell…